|
1
|
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women.
|
Blood
|
2011
|
1.78
|
|
2
|
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.
|
Blood
|
2011
|
1.33
|
|
3
|
An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF.
|
Blood
|
2009
|
1.27
|
|
4
|
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.
|
Haematologica
|
2011
|
0.99
|
|
5
|
Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF.
|
Blood
|
2014
|
0.85
|
|
6
|
Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease.
|
Thromb Haemost
|
2006
|
0.83
|
|
7
|
Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain.
|
Blood
|
2010
|
0.81
|
|
8
|
Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
|
Thromb Haemost
|
2017
|
0.75
|
|
9
|
Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship.
|
Haematologica
|
2007
|
0.75
|